Lack of association between serum adiponectin levels and the Pro12Ala polymorphism in Asian Indians

Aims  The aim of the study was to investigate the association of serum adiponectin levels with the Pro12Ala polymorphism of the peroxisome proliferator activated receptor‐γ (PPARG) gene in Asian Indians.

[1]  V. Mohan,et al.  Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). , 2005, Metabolism: clinical and experimental.

[2]  S. Grundy,et al.  Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. , 2004, The Journal of clinical endocrinology and metabolism.

[3]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[4]  M. Marmot,et al.  Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans , 1992, Diabetologia.

[5]  V. Mohan,et al.  Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects , 1986, Diabetologia.

[6]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[7]  V. Mohan,et al.  The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). , 2003, The Journal of the Association of Physicians of India.

[8]  M. Matsuda,et al.  Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.

[9]  M. Stumvoll,et al.  CORRESPONDENCE No Influence of the PPAR 2 Pro12Ala Genotype on Serum Adiponectin Concentrations in Healthy Europeans , 2003 .

[10]  T. Saruta,et al.  PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. , 2002, Metabolism: clinical and experimental.

[11]  Lee-Ming Chuang,et al.  Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. , 2002, Diabetes care.

[12]  N. Cox,et al.  Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  N. Abate,et al.  Ethnicity and type 2 diabetes: focus on Asian Indians. , 2001, Journal of diabetes and its complications.

[14]  M. Stumvoll,et al.  Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. , 2001, Diabetes.

[15]  M. Kasuga,et al.  The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. , 2001, Diabetes.

[16]  J. Beilby,et al.  A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. , 2001, European journal of endocrinology.

[17]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.

[18]  T. Kadowaki,et al.  The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes , 2000 .

[19]  J. Auwerx,et al.  Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus , 2000, International Journal of Obesity.

[20]  S. Grundy,et al.  Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  C. Yen,et al.  Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. , 1998, Diabetes.

[22]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[23]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[24]  B. Spiegelman PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.

[25]  J. Levy,et al.  Insulin Resistance in Patients of Asian Indian and European Origin with Non-Insulin Dependent Diabetes , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.